Competing Rulings Issued on Access to Mifepristone, FDA Seeks Emergency Appellate Relief | Foley Hoag LLP
Key Takeaways: Two competing federal court preliminary injunction orders were issued April 7, 2023, which have put the continued availability of mifepristone, the primary drug used for...